Latest filing published 23 Jan 2026 for ENDRA Life Sciences Inc.. Read the official filing
Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Anthony Digiandomenico is a declared insider at 2 companies; the most frequent names are MDB Capital Holdings, LLC and ENDRA Life Sciences Inc. The record holds 19 filings, for trades running from 2 May 2023 to 21 January 2026.
Every open-market trade on record is a purchase: 15 purchases worth €151k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants and 1 option exercise.
A typical purchase (the median) is worth €5,535. On 1 out of 13 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 10 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -29.5%. These figures describe past trades and do not predict future prices.
The record was last updated on 23 January 2026 with a share grant in ENDRA Life Sciences Inc. The latest purchase dates back some time: it was published 436 days ago, on 8 August 2025. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations